Clinical Trials Directory

Trials / Completed

CompletedNCT01378130

Central Serous Chorioretinopathy: Etiology, Course and Prognosis

Central Serous Chorioretinopathy: An Observational Study About Etiology, Course and Prognosis

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pathogenesis of central serous chorioretinopathy is not entirely understood yet, therefore further investigations are needed. During this study patients with an acute episode of central serous chorioretinopathy are observed with established ophthalmologic methods (multimodal imagine) every 6 weeks until subretinal fluid is reabsorbed to gain further insides in etiology, course and prognosis of this disease.

Detailed description

Patients with central serous chorioretinopathy are recruited from the Department of Ophthalmology at the Medical University of Vienna. All patients undergo ETDRS visual acuity measurement, Pelli-Robson contrast examination, Amsler-Grid testing, questionnaire testing, ophthalmologic examination, SD-OCT and polarization-sensitive OCT, fundus autofluorescence, fluorescein angiography, indocyanine-green angiography, fundus photo and microperimetry. Patients are re-examined after an interval of 6 weeks until subretinal fluid is entirely reabsorbed to gain further insides in etiology, course and prognosis of this disease.

Conditions

Timeline

Start date
2011-04-01
Primary completion
2013-04-01
Completion
2013-04-01
First posted
2011-06-22
Last updated
2013-04-26

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT01378130. Inclusion in this directory is not an endorsement.

Central Serous Chorioretinopathy: Etiology, Course and Prognosis (NCT01378130) · Clinical Trials Directory